As Seen on the Show

Revolutionary Implantable Lens Offers Millions Hope for Restored Vision

Alcon

Cloudy vision, muted colors, difficulty driving – cataracts can have a major impact on someone’s life. More than 20 million people in the U.S. over the age of 40 have cataracts.

Cataracts are one of the most common conditions associated with aging and one of the leading causes of age-related vision impairment in the United States.

Today, there are 20 million people in the U.S. over the age of 40 who have cataracts –a clouding in the eye’s naturally clear lens, that blocks or changes how light passes through, resulting in blurry vision.

There is new hope for cataract sufferers – not only to remove their cataracts — but to restore vision – sometimes resulting in better vision than they have ever had.

Surgery can correct cataracts and enhance your vision by implanting cataract replacement lenses, often called intraocular lenses or IOLs. The FDA recently approved the AcrySof® IQ PanOptix® Trifocal IOL by Alcon – the first and only trifocal lens in the U.S. engineered to provide vision at every distance, from near, intermediate and far – significantly reducing the need for glasses after surgery.

“PanOptix® is the first Trifocal lens approved in the United States,” said Robert Cionni, M.D., a world-renowned expert in cataract surgery and a lead PanOptix clinical trial investigator. “With the Trifocal lens the lens can focus at multiple distances.  It brings the eyes back to a more youthful state.”

“I never heard of it and I’m an artists.  I was having issues seeing color, also driving.  I quit. It was frustrating for me,” said patient Barbara Badge. “I am blown away and more than I ever expected and hope flooded over me after speaking with Dr. Cionni.  I have 20/20 vision in each eye and it’s a miracle.”

“The procedure lasts about 15 minutes,” said Dr. Cionni. “Within a day, we tell patients that they should be able to drive without their glasses.”

Visit: www.MyCataracts.com